Matt Brow serves as the president and general manager of Inovalon’s data-driven advisory business through Avalere Health. Avalere is a vibrant community of innovative thinkers dedicated to solving the challenges of the healthcare ecosystem through data-driven advisory services and business intelligence capabilities. In this role, Mr. Brow leads the organization’s focus on bringing data-enabled strategic guidance and tools to the full array of healthcare companies – from pharmaceuticals and life sciences, to managed care and providers. Unique to the Inovalon data-driven advisory services is the ability to combine analytical insights informed by billions of medical events with industry-leading subject matter and policy expertise, together powering configurations of the Inovalon ONE® Platform to bring resulting solutions to the marketplace in large-scale. Mr. Brow has extensive experience managing cross-functional teams and has engaged internal and external healthcare stakeholders to find consensus and achieve stable business growth.
Preceding his roles at Avalere, Mr. Brow served as Senior Vice President of Operations, for the US Oncology Network at McKesson Specialty Health, where he was responsible for developing, planning and directing the operations of the Network across a multi-state territory. His work included driving organization objectives to ensure financial stability through short- and long-range planning to achieve and maintain sustained profitable growth.
Previously, Mr. Brow held roles at McKesson and its predecessor company, US Oncology, where he led public policy; mergers and acquisitions; business development; go-to-market strategy; sales; reimbursement strategy; federal and state government relations; and communications. Prior to joining US Oncology, he served as a consultant, advising clients on state government affairs strategy across a wide-range of healthcare and political issues.
Mr. Brow has published widely in peer-reviewed and professional journals on healthcare policy, the Affordable Care Act, cancer care quality, and value-based care. He holds a BA in history and political science from the University of Richmond.